Written by Klarity Editorial Team
Published: Aug 31, 2026

Last updated: August 31, 2026
If you hold an Aetna commercial card in Texas and you want help with weight, many employer and individual plans may cover an evaluation and some anti-obesity medicines. Coverage is not automatic. Mental health parity does not force a plan to pay for GLP-1s. Your Summary of Benefits and Coverage (SBC), exclusions, BMI criteria, and CVS/Caremark formulary decide what you pay.
See if you may qualify for online weight-loss care · Browse conditions
Many Aetna commercial members in Texas may receive coverage for a medically necessary obesity evaluation, nutrition counseling when listed as a benefit, and some prescription weight-loss medicines. That is a typical design, not a guarantee. Many groups still exclude “weight-loss drugs,” require a documented BMI threshold, demand prior authorization, or limit quantity.
Klarity Health works with 2,000+ licensed providers. A licensed clinician can evaluate history, discuss options, and, when medically appropriate, prescribe. Klarity does not promise that Aetna will pay a specific claim.
Verify your benefits for online weight-loss care
Aetna is a CVS Health company. Commercial pharmacy for many Aetna members uses CVS/Caremark. That PBM is not Carelon Rx (common on Anthem) and not Express Scripts (common on Cigna). Mixing those lists is a frequent reason members misread coverage.
Related Texas cluster pages:
Federal MHPAEA generally requires that financial requirements and treatment limitations for mental health and substance use disorder benefits be no more restrictive than those for medical/surgical benefits in the same classification. Texas adds Insurance Code Chapter 1355. TDI’s overview is here: Insurance coverage and parity for mental health and substance use.
Obesity pharmacotherapy is typically classified as a medical/pharmacy benefit, not a mental health benefit. Chapter 1355 does not convert Wegovy or Zepbound into a mandated mental health drug. If your plan excludes anti-obesity agents, parity usually will not override that exclusion.
Texas Insurance Code Chapter 1455 addresses coverage for telemedicine and telehealth when a health benefit plan covers the same service in person. A covered obesity visit delivered by video may therefore be payable at the in-person rate, subject to the same cost sharing, if the clinician and platform meet the statute and your contract. Self-funded ERISA plans may follow federal rules instead of Chapter 1455. Confirm with the plan administrator.
CVS Caremark removed Zepbound from many commercial formularies on July 1, 2025. On May 28, 2026, CVS Health said Caremark will add Zepbound back to commercial formularies as an additional preferred option on October 1, 2026 (CVS Health announcement). Until that date, many Aetna commercial members still follow the post-2025 list. After October 1, 2026, preferred status still depends on your employer’s adopted formulary, prior authorization, and step therapy. Cigna/ESI did not follow the same Zepbound removal. Do not copy Cigna IP0477 onto Aetna obesity claims.
Common prescription options a clinician may discuss include GLP-1s (Wegovy, Zepbound), phentermine, phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), and orlistat. Phentermine and Qsymia are Schedule IV. GLP-1s, Contrave, and orlistat are typically unscheduled. Your Caremark list still decides tier, quantity limits, and whether a specialty pharmacy is required.
HHS and DEA extended COVID-era telemedicine flexibilities for prescribing controlled medications through December 31, 2026 (HHS). That window can affect phentermine and Qsymia. It does not change whether Caremark pays the claim. Unscheduled GLP-1s, Contrave, and orlistat do not rely on that controlled-substance flexibility.
NCHS reports that during August 2021–August 2023, the prevalence of obesity among U.S. adults was 40.3% (CDC NCHS Data Brief 508). An earlier NHANES window (2017–March 2020) put adult obesity at 41.9% (CDC Adult Obesity Facts). High prevalence does not create an Aetna mandate to cover a specific drug.
If you have Medicare Part D or a Medicare Advantage plan with drug coverage, CMS runs a separate Medicare GLP-1 Bridge from July 1, 2026 through December 31, 2027. Eligible beneficiaries may access certain GLP-1s (Wegovy, Zepbound, Foundayo) at $50 per month under that demonstration (CMS press release). That is a Medicare program. It is not CVS/Caremark commercial coverage and it does not apply to Medicaid STAR or CHIP.
Aetna Medicare Advantage, when you have it, follows CMS 42 CFR Part 422, not Texas Chapter 1355 as the controlling appeal path. After the plan’s organization determination, federal review typically goes to the Independent Review Entity (Maximus) at 1-855-887-6668, then an ALJ if needed. TDI does not run Medicare appeals.
Texas Medicaid STAR and CHIP are not Aetna commercial products. Formulary, telehealth, and prior authorization follow HHSC rules. This guide does not describe STAR coverage. If your card is Medicaid, call the number on the back of the card.
TDI Consumer Protection Help Line: 800-252-3439, 8 a.m. to 5 p.m. Central, Monday–Friday (TDI contact). Use TDI for Texas-regulated commercial complaints, not Medicare.
A Klarity clinician reviews history, medications, and goals, screens for contraindications, and discusses lifestyle plus medication options when appropriate. If a prescription is indicated, the clinician sends it to a pharmacy that can fill under your benefits. You still verify copay and prior authorization with Aetna and Caremark.
See if you may qualify for online weight-loss care
Sometimes. Coverage depends on whether anti-obesity agents are a covered class, your Caremark list, PA, and BMI rules. Zepbound’s Caremark preferred-status change on October 1, 2026 may help some commercial members. Confirm on your own list.
Usually no. MHPAEA and Chapter 1355 target mental health and substance use benefits. Obesity drugs sit on the medical/pharmacy side.
A Texas-licensed clinician may prescribe when medically appropriate and when federal telemedicine rules for Schedule IV drugs allow it through December 31, 2026. Insurance payment is a separate Caremark question.
Start with Aetna’s internal appeal on the denial letter. For Texas-regulated commercial plans, TDI Help Line 800-252-3439. For Medicare Advantage, use the plan appeal then Maximus IRE 1-855-887-6668.
This article is educational. It is not medical, legal, or benefits advice. Coverage varies by plan. Verify benefits with Aetna and CVS/Caremark before you book. If you are in crisis, call or text 988.
Check if your plan may cover online weight-loss care · Browse conditions
Find the right provider for your needs — select your state to find expert care near you.